Components of tissue engineering

gaurav11288 3,870 views 74 slides Dec 08, 2012
Slide 1
Slide 1 of 74
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74

About This Presentation

Find more related content at www.PharmInfopedia.com


Slide Content

Tissue Engineering OverviewTissue Engineering Overview

•Can I live with a beating heart that
came from no one?

•Interdisciplinary field that applies the
principle of engineering and life
sciences to the development of
biological substitutes that restore,
maintain or augment tissue function

Tissue EngineeringTissue Engineering
•An alternative to drug therapy, gene
therapy and whole organ transplantation
–Gene and drug therapy an option for treating
the underlying disease if the molecular basis
of the disease is understood
–Less suitable for replacing the entire function
of the cell
–“Grow” organs in the lab

Insoluble
Matrix
Assemblies
CELLS
Cells
Soluble Matrix
Molecules
Regulators of
Matrix
Assembly
Matrix Bound
Growth
Factors
Bioactive
Matrix
Soluble Growth
Factors

Steps in Tissue EngineeringSteps in Tissue Engineering
•Appropriate cell source must be identified,
isolated and produced in sufficient numbers
•Appropriate biocompatible material that can be
used as a cell substrate or cell encapsulation
material isolated or synthesized, manufactured
into desired shape and dimensions
•Cells seeded onto or into material, maintaining
function, morphology
•Engineered structure placed into appropriate in
vivo site

Extracellular MatrixExtracellular Matrix
•Cell growth and differentiation in 2D
cell culture and 3D organ culture
requires presence of structured
environment with which cells can
interact
•ECM – polymeric networks of several
types of macromolecules in
combination with smaller molecules,
ions and water

ECMECM
•Composed of:
–Fibrous proteins
•Collagens
•Elastin
•Fibrillin
•Fibronectin
•Laminin
–Hydrophilic proteoglycans
•Assembled by cells, modified by cells as
they proliferate, differentiate, and migrate

•Recognized that it is not inert
•Influences cell shape, fate, metabolism
•Detailed characterization of ECM essential
for understanding behaviour of cells
•Structure, signaling, regulators of cell
behaviour
•Hugely varied
–Hard tissues of bone and teeth
–Transparent matrix of the cornea
–Ropelike organization of tendons

•GAG and proteoglycan molecules
form highly hydrated gel-like
“ground substance” in which the
fibrous proteins are embedded
•Aqueous phase permits diffusion of
nutrients
•Collagen fibres strengthen and
organize matrix
•Elastin fibres give resiliance
•Adhesive proteins help cells to
attach to ECM

•Secreted in many cases by cells as
precursor molecules
•Significantly modified before assembly
with other components into functional
polymers
–Proteolytically processed
–Sulfated
–Oxidized
–Cross linked
•Formation is unidirectional, irreversible
•Polymers reconstituted in lab with
components extracted from ECM do not
have all properties as when assembled by
cells

•ECM is also modified by cells as they
proliferate, differentiate, and migrate
•Cells continually interact with matrix
•Communication pathway
•ECM influences cell shape, fate and
metabolism
•Understanding of ECM is therefore
essential to understanding cell behaviour
in context of tissue and organ
development and function
–Structural components (collagen, elastin)
–Signalling molecules (matrix bound GF’s)
–Multidomain molecules

CollagensCollagens
•Major scaffold proteins of ECM
•Family of proteins
•Most abundant protein in mammals, up to 30%
of all proteins
•Responsible for functional integrity of tissues
such as cartilage, skin, tendon
•15 collagen types present in human tissues
•High tensile strength, equivalent to steel when
compared on cross-sectional area, factor of
three greater on a per weight basis

Diagram from Nimni
Diagram page 49 TE book
The Collagen MoleculeThe Collagen Molecule

The Collagen MoleculeThe Collagen Molecule
"a chain
–Gly-X-Y tripeptide sequence
–Y frequently Pro, Hyp
–Proline, OH-proline follow each other relatively
frequently
–Gly-Pro-Hyp sequence makes up about 10% of
molecule
–Types I-III collagen, MW 100 kDa, 1000 amino
acids
–Stabilized by hydrogen bonds (1-2 per 3 amino
acids
–Molecular rods 30 nm in length, 1.5 nm in
diameter

FibrillogenesisFibrillogenesis
Figure 9 Nimni

Types of CollagenTypes of Collagen
Figure 11 Nimni

Type I CollagenType I Collagen
•Three chains, two a1 chains, 1 a2
chain
•Abundant in skin, tendon, ligament,
bone, cornea – 88-99% of total
collagen

Type II CollagenType II Collagen
•Present in large amounts in cartilage
•Also present in intervertebral disk,
vitreous humour of the eye

Type III CollagenType III Collagen
•Present in small amounts in skin, larger
amounts in blood vessels, absent in bone
•Associated with Type I collagen
•Seems to located predominantly at the
fibril surface, appears to mediate
interactions between fibrils, important for
mechanical properties of tissues

Figure 12 from Nimni

•Other structural or fiber forming
collagens – Types V and IX
•Type V collagen is abundant in
vascular tissues produced by blood
vessels
•Also present in avascular corneal
stroma

Basement Membrane Basement Membrane
CollagensCollagens
•Type IV collagen major component of
basement membranes
•Does not organize into fibrillar structure
•Resembles procollagen with
carbohydrates accounting for 10% of the
mass
•Associated with a large number of non-
collagenous molecules as well as Type VII
collagen

ElastinElastin
•Source of elasticity in tissues
•Prominent in lung, skin and blood
wall

ElastinElastin
•Necessary for providing tissue with elasticity
so that they can recoil after transient stretch
•Extensibility that is five times that of elastic
band with same cross-sectional area
•Highly insoluble
•Composed of alternating hydrophobic and Ala
and Lys rich crosslinking domains
•Hydrophobic domains contain repetitive
sequences of 3-9 uncharged amino acids

•Lys domains oxidized by enzyme lysyl oxidase
to form aldehydes and extensive crosslinks
between neighbouring molecules in the fibre
•Elasticity driven by hydrophobic interactions,
tendency of hydrophobic segments to adopt a
random coil configuration following stretch
•Tropoelastin – soluble precursor of elastin
•Can form extensive crosslinks with multiple
adjacent tropoelastins providing for potential
extensive networking

MicrofibrilsMicrofibrils
•Other component of elastic fibers
•Complex of glycoproteins organized into
small 10-12 nm diameter tubular fibrils
•Fibrillin major component
•Contain many charged and basic amino
acids including cysteines
•Importance highlighted in diseases
including Marfan syndrome

•Other molecules (proteoglycan) are seen
in association with elastin including
–Decorin
–Hyaluronic acid
–Dermatan sulfate
•May provide hydration necessary for
elastic recoil or prevent spontaneous
aggregation of tropoelastin in extracellular
space allowing fibrillogenesis to occur

Tissue Distribution of Tissue Distribution of
Elastic FibresElastic Fibres
•Abundant is tissues subjected to
repetitive deformation
–Blood vessel wall
–Alveolar septal interstices
–Deep dermal layers
–Elastic cartilage
•Amount varies depending on physical
demands on tissue – 30-75% of dry
weight of tissue

•Organized into three distinct
morphological forms
–Elastic ligaments skin and lungs –
fibers are small and rope-like
–In blood vessels – concentric sheets or
lamellae interconnected by fine elastic
fibers
–Cartilage – organize as trabecular
network

GlycosaminoglycansGlycosaminoglycans
•Long, unbranched polysaccharide chains
composed of repeating sugar units
•70-200 sugar residues long
•Highly negatively charged due to sulfate
and carboxyl groups
•One of two sugar residues in repeating
disaccharide is always an amino sugar
–N-acetylglucosamine
–N-acetylgalactosamine

•Four main groups of GAGs,
distinguished by sugar residues,
type of linkage between residues and
number and location of sulfate
groups
–Hyaluronic acid
–Chondroitin sulfate and dermatan
sulfate
–Heparan sulfate and heparin
–Keratan sulfate

•Too inflexible to fold into compact
globular structures
•Strongly hydrophilic
•Tend to adopt highly extended random
coil configurations, huge volume relative
to mass
•Form gels, even at very low
concentrations, filling most of the
extracellular space, providing
mechanical support for the tissues

The GlycosaminoglycansThe Glycosaminoglycans
GAG MW A B SulfatesProteinOther
Sugars
Tissues
HA 4000 –
8x10
6
Glucuronic
acid
Glucos-
amine
0 - 0 Skin,
vitreous,
cartilage
CS 5000-
50000
Glucuronic
acid
Galacto
s-amine
0.2 – 2.3+ Galactos
exylose
Cartilage
Cornea
Bone
HS 5000-
12000
Glucuronic
acid
Glucos-
amine
0.2-2.0 + Galactos
exylose
Lung,
arteries
KS 4000-
19000
GalactoseGlucos-
amine
0.9-1.8 + Galactos-
amine
Cartilage
cornea

ProteoglycansProteoglycans
•Core protein with one or more covalently
bound linear polysaccharide chains
(GAGs)
•Important in migrating and proliferating
cells
•Allow cartilage to withstand compressive
forces
•Regulate adhesion, migration,
proliferation, mechanical roles

ProteoglycansProteoglycans
•Except for HA, all GAG’s found linked to
protein
•Usually easily distinguishable from
glycoproteins by nature and arrangement
of sugar side chains
•Glycoproteins 1-60% carbohydrate by
weight, 300 000 Da or less
•Proteoglycans – up to 95% carbohydrate
by weight – 3 000 000 Da or more

•Potential for limitless heterogeneity
•Can differ markedly in protein
content, molecular size, number and
type of GAGs
•Very difficult to characterize and
classify

Function of ProteoglycansFunction of Proteoglycans
•Bind various secreted signaling molecules in
vitro
•Form gels of varying pore size and charge
density, functioning as sieves to regulate
traffic of molecules and cells
•Difficult to determine arrangement in vivo
since highly water soluble and readily
washed away

Cell Interactive GlycoproteinsCell Interactive Glycoproteins
•Bind to both cells and ECM
•Fibronectin (RGDS, REDV)
•Laminin (YIGSR, IKVAV, PDSGR)
•Vitronectin (RGDV)

IntegrinsIntegrins
•Communication channels for cells
•Cell cell and cell matrix binding
•Bind to cell surface receptors

Growth FactorsGrowth Factors
•Found in vitro that application of
certain proteins applied to wounds
accelerate normal rate of healing
•Important to process of wound
healing

•Most important biologically active
group of molecules to be identified
•Generally small to medium sized
proteins and glycoproteins
•Mediate potent biological effects on
all cell types
•Involved in all physiological
processes

CytokinesCytokines
•Interleukins
•Interferons
•Cytotoxins
•Colony Stimulating Factors
•Growth Factors
•Suppressor, Inhibitory Factors

•Stimulate or inhibit
–Cell proliferation
–Differentiation
–Migration
–Adhesion
–Gene expression
–Secretion and action of other growth
factors
•Different growth factors share the
same biological effects

•Most show more than one property and
are able to mediate vast array of
biological functions (pleiotropic)
•Currently 100+ have been discovered, 20
different families based on structural
homology
•Not stored as preformed molecules
•Require proteolytic activation
•May need to bind to ECM for activity and
stabilization

•Synthesis is initiated by new gene
transcription
•Act by binding to cell surface receptors
•Important autocrine and paracrine
regulators of cell growth and function
•Names indicative of original location of
discovery, not range of potential effects
•Characterized by short biological half
lives (PDGF, 2 minutes in blood for
example)

Epidermal Growth FactorEpidermal Growth Factor
•Most characterized growth factor
•53 amino acids, 6 kDa
•Stimulatory for wide variety of cell types
•Initial changes include
–Increase in active transport of low MW
compounds
–Protein phosphorylation
–Membrane translocation
–Receptor internalization

EGF diagram

The EGF Receptor as a ModelThe EGF Receptor as a Model

Receptor Ligand BindingReceptor Ligand Binding
•Often monitored using
125
I
•Incubation of cells with ligand for
specified time
•Rapid removal of unbound ligand
•Measurement of radioactivity
•Non specific binding is measured by
adding high concentrations of
unlabeled growth factor to system

Specific binding diagram

Receptor + Ligand diagram
CLR
f
r
k
k
«+
D
f
r
D
k
k
K
RL
C
k
k
K
CLR
f
r
=
=
«+

•K
D
is equilibrium dissociation
constant
•Small K
D, high K
A (K
D
-1
), equilibrium
association constant, means high
affinity of receptor for ligand
•High affinity K
D
= 10
-15
•Low affinity K
D
= 10
-6
•Function of temperature, pH

CooperativityCooperativity
•Binding constants – K
D
and one or
both of k
r
and k
f
– vary with extent of
receptor occupancy

•Believed that EGF and receptor are
monovalent
•EGF receptor thought to be able to
dimerize in some studies
•Dimerization seems to be enhanced by
presence of EGF
•Affinity of EGF for dimerized receptors
possibly higher than for monomeric
receptors
•Mathematical model allows understanding
of complex surface interactions

Receptor Ligand TraffickingReceptor Ligand Trafficking

Receptor DownregulationReceptor Downregulation
•Can lead to receptor downregulation
•Essentially loss of cell surface
receptors
–Endocytotic (internalization step)
–Sorting
–Synthetic

CellsCells
•Identification of a cell source remains a
significant problem
•In some cases ingrowth of host cells can
lead to the generation of new tissue
•In most cases difficult to obtain adequate
numbers of cells in order to maintain
cellular function
•Stem cells are a possibility